Despite increasing interest and investigation devoted to understanding the relationship between cocaine use and cardiovascular disease, there remain considerable voids in our understanding of the mechanisms whereby cocaine impacts on the cardiovascular system. Among the reasons for the slow progress is the lack of appropriate models suitable for chronic study which are both relevant to the human condition, yet allow for experimental manipulations which cannot be performed in humans for both technical and ethical reasons. With support from NIDA, prior studies from this laboratory employing conscious, chronically instrumented dogs, have demonstrated new findings which have challenged previous notions as to the mechanisms and effects of acute cocaine administration on both the coronary circulation and myocardial function, serving to underscore both the relevance of and the need for studies in larger animals in the conscious state. We hypothesize that the effects of chronic cocaine exposure are not merely the sum of its acute effects over time, but rather reflect dynamic alterations in signal transduction pathways which vary with both duration and intensity of exposure and with the component of the cardiovascular system studied (e.g. coronary vascular versus myocardial effects). Specifically, we will characterize and contrast the effects of chronic cocaine exposure compared to acute exposure on the systemic and the coronary circulations. Secondly, we will characterize the effects of chronic cocaine exposure on coronary flow and vasodilator reserve, as potential mechanisms whereby cocaine might predispose to ischemia in the absence of obstructive coronary artery disease. Thirdly, we will determine if the altered coronary vascular responsiveness to binge cocaine use is perpetuated following chronic use and the extent to which altered adrenergic and non adrenergic (nitric oxide) mechanisms contribute to the impairment. Furthermore, we will determine if there is coronary vascular sensitization to adrenergic and non adrenergic vasoconstrictor substances and the role of functionally impaired endothelial responses following chronic daily binge exposure as well as the extent to which these abnormalities are reversible upon cessation of chronic cocaine use. Finally, we will examine the effects of chronic cocaine use not as a trigger to ischemic events, but as a potentiator of the adverse consequences when superimposed against a backdrop of acute myocardial ischemia or impaired myocardial contractile dysfunction. Taken together, these proposed studies will yield new insights into the pathophysiological mechanisms whereby chronic cocaine use predisposes to ischemic insults through alterations in coronary vascular responses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
7R01DA010480-02
Application #
2458471
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1996-09-01
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Type
Other Domestic Higher Education
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Katz, Joel T; Shannon, Richard P (2006) Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation 113:920-2
Zhao, Tingcun; Parikh, Pratik; Bhashyam, Siva et al. (2006) Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther 317:1106-13
Parikh, Pratik; Nikolaidis, Lazaros A; Stolarski, Carol et al. (2005) Chronic exposure to cocaine binging predisposes to an accelerated course of dilated cardiomyopathy in conscious dogs following rapid ventricular pacing. J Pharmacol Exp Ther 315:1013-9
Nikolaidis, Lazaros A; Elahi, Dariush; Shen, You-Tang et al. (2005) Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 289:H2401-8
Nikolaidis, Lazaros A; Mathier, Michael A; Doverspike, Aaron et al. (2005) Coronary blood flow responses are impaired independent of NO and endothelial function in conscious dogs with dilated cardiomyopathy. J Card Fail 11:313-21
Nikolaidis, Lazaros A; Trumble, Dennis; Hentosz, Teresa et al. (2004) Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure). Eur J Heart Fail 6:409-19
Nikolaidis, Lazaros A; Sturzu, Anthony; Stolarski, Carol et al. (2004) The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61:297-306
Nikolaidis, Lazaros A; Elahi, Dariush; Hentosz, Teresa et al. (2004) Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 110:955-61
Nikolaidis, Lazaros A; Hentosz, Teresa; Doverspike, Aaron et al. (2002) Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure. Cardiovasc Res 53:392-404
Nikolaidis, Lazaros A; Doverspike, Aaron; Huerbin, Rhonda et al. (2002) Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 105:2785-90

Showing the most recent 10 out of 16 publications